GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NetScientific PLC (FRA:NTK1) » Definitions » Institutional Ownership

NetScientific (FRA:NTK1) Institutional Ownership : 0.60% (As of Jun. 10, 2024)


View and export this data going back to 2013. Start your Free Trial

What is NetScientific Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NetScientific's institutional ownership is 0.60%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NetScientific's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NetScientific's Float Percentage Of Total Shares Outstanding is 0.00%.


NetScientific Institutional Ownership Historical Data

The historical data trend for NetScientific's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetScientific Institutional Ownership Chart

NetScientific Historical Data

The historical data trend for NetScientific can be seen below:

2022-08-31 2022-09-30 2022-10-31 2022-11-30 2022-12-31 2023-01-31 2023-02-28 2023-03-31 2023-04-30 2023-05-31
Institutional Ownership 2.31 2.31 2.31 2.14 2.13 2.13 2.13 2.07 1.37 0.60

NetScientific Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


NetScientific (FRA:NTK1) Business Description

Traded in Other Exchanges
Address
20 Saint Andrew Street, Holborn Circus, London, GBR, EC4A 3AG
NetScientific PLC is a transatlantic healthcare technology company. The group is focused on sourcing, funding and commercializing technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients, Glucosense a provider of a non-invasive glucose monitoring wearable device, Vortex Biosciences which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing, and Glycotest which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis.

NetScientific (FRA:NTK1) Headlines

No Headlines